Summary:
Houston Endoscopy & Research Center is conducting an Open-label, Long-term Study to Assess the Immunogenicity of Linaclotide Administered Orally to Adult Patients with Irritable Bowel Syndrome with Constipation or Chronic Idiopathic Constipation
>>Symptoms may include: abdominal pain or discomfort and reduced stool
frequency, bloating,hard stools, straining, and a sensation of incomplete evacuation.
*Study drug and study related medical care at no cost. Health insurance is not necessary to participate.
*Compensation for time and travel may be provided for those who qualify.
Qualified Participants Must:
• Be 18 years of age or older
•
Be experiencing constipation/IBS-C for at least 6 months